ctrl K

Price Alert

Terns Pharmaceuticals Inc... (TERN)

NASDAQ: TERN · Real-Time Price · USD

7.64

0.20 (2.69%)

At close: Sep 26, 2025, 3:59 PM

7.64

0.00%

After-hours: Sep 26, 2025, 04:13 PM EDT

Terns Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	1M
Cost of Revenue	n/a	881K	1.03M	512K
Gross Profit	n/a	-881K	-1.03M	488K
Operating Income	-101.87M	-102.56M	-62.03M	-49.86M
Interest Income	13.29M	12.9M	2.11M	170K
Pretax Income	-88.59M	-89.97M	-59.99M	-49.65M
Net Income	-88.85M	-90.21M	-60.34M	-50.16M
Selling & General & Admin	31.76M	39.06M	22.41M	19.55M
Research & Development	70.11M	63.5M	39.62M	31.31M
Other Expenses	n/a	n/a	-68K	40K
Operating Expenses	101.87M	102.56M	62.03M	50.86M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	102.56M	62.03M	50.86M
Income Tax Expense	260K	239K	358K	508K
Shares Outstanding (Basic)	79.51M	71.26M	36.03M	25.27M
Shares Outstanding (Diluted)	79.51M	71.26M	36.03M	25.27M
EPS (Basic)	-1.12	-1.27	-1.67	-1.98
EPS (Diluted)	-1.12	-1.27	-1.67	-1.98
EBITDA	-87.7M	-102.27M	-58.95M	-49.35M
EBIT	-88.59M	-102.56M	-62.03M	-49.86M
Depreciation & Amortization	896K	292K	1.03M	512K

Ask AI